| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| G1PNJ4_MYOLU | NKX2-2 | ENSMLUP00000012521 | ENSMLUP00000008537 | Uncharacterized protein. | NK2 homeobox 2. | 0.783 |
| G1PNJ4_MYOLU | PAX6 | ENSMLUP00000012521 | ENSMLUP00000005952 | Uncharacterized protein. | Paired box 6. | 0.527 |
| G1PNJ4_MYOLU | TLE1 | ENSMLUP00000012521 | ENSMLUP00000002810 | Uncharacterized protein. | TLE family member 1, transcriptional corepressor. | 0.904 |
| INS | NEUROG1 | ENSMLUP00000003521 | ENSMLUP00000004158 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Neurogenin 1. | 0.613 |
| INS | NEUROG3 | ENSMLUP00000003521 | ENSMLUP00000019233 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Neurogenin 3. | 0.728 |
| INS | NKX2-2 | ENSMLUP00000003521 | ENSMLUP00000008537 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | NK2 homeobox 2. | 0.773 |
| INS | PAX6 | ENSMLUP00000003521 | ENSMLUP00000005952 | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Paired box 6. | 0.878 |
| NEUROG1 | INS | ENSMLUP00000004158 | ENSMLUP00000003521 | Neurogenin 1. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.613 |
| NEUROG1 | NKX2-2 | ENSMLUP00000004158 | ENSMLUP00000008537 | Neurogenin 1. | NK2 homeobox 2. | 0.804 |
| NEUROG1 | OLIG3 | ENSMLUP00000004158 | ENSMLUP00000021956 | Neurogenin 1. | Oligodendrocyte transcription factor 3. | 0.514 |
| NEUROG1 | PAX6 | ENSMLUP00000004158 | ENSMLUP00000005952 | Neurogenin 1. | Paired box 6. | 0.803 |
| NEUROG3 | INS | ENSMLUP00000019233 | ENSMLUP00000003521 | Neurogenin 3. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.728 |
| NEUROG3 | NKX2-2 | ENSMLUP00000019233 | ENSMLUP00000008537 | Neurogenin 3. | NK2 homeobox 2. | 0.832 |
| NEUROG3 | OLIG3 | ENSMLUP00000019233 | ENSMLUP00000021956 | Neurogenin 3. | Oligodendrocyte transcription factor 3. | 0.514 |
| NEUROG3 | PAX6 | ENSMLUP00000019233 | ENSMLUP00000005952 | Neurogenin 3. | Paired box 6. | 0.868 |
| NKX2-2 | G1PNJ4_MYOLU | ENSMLUP00000008537 | ENSMLUP00000012521 | NK2 homeobox 2. | Uncharacterized protein. | 0.783 |
| NKX2-2 | INS | ENSMLUP00000008537 | ENSMLUP00000003521 | NK2 homeobox 2. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.773 |
| NKX2-2 | NEUROG1 | ENSMLUP00000008537 | ENSMLUP00000004158 | NK2 homeobox 2. | Neurogenin 1. | 0.804 |
| NKX2-2 | NEUROG3 | ENSMLUP00000008537 | ENSMLUP00000019233 | NK2 homeobox 2. | Neurogenin 3. | 0.832 |
| NKX2-2 | OLIG3 | ENSMLUP00000008537 | ENSMLUP00000021956 | NK2 homeobox 2. | Oligodendrocyte transcription factor 3. | 0.815 |
